Here, we also demonstrated evidence showing that triglycerides might influence the aggressiveness and severity of PCa; further studies are needed to assess the relationship between these lipids and PSA levels in men with PCa, and extensive clinical validation of these novel PCa biomarkers remains one of the most significant challenges. This evidence concerns the gene KLK3 and posterior cortical atrophy.